Best in Biotech 2 Aug 2024 Six epigenetics companies making strides in 2024 …that the drug stimulates immune cells and enhances anti-tumor properties in combination with checkpoint inhibitors. Storm also has preclinical candidates being designed to treat Alzheimer’s disease and other neurodegenerative conditions… August 2, 2024 - 7 minutesmins - By Roohi Mariam Peter Share WhatsApp Twitter Linkedin Email
More News! 16 Oct 2018 Drug Combination for Rare Genetic Nerve Disorder Nails Phase III …to launch two clinical trials for another drug formulation in 2019, a Phase IIb in Alzheimer’s and a Phase IIa in amyotrophic lateral sclerosis. The company is also working with… October 16, 2018 - 2 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 28 Jul 2022 Biogen’s New Drug Application for first treatment of rare form of neurological disease accepted by FDA …for the company as last month, (June) it said it was forced to end an observational trial of Alzheimer’s drug, Aduhelm, after a ruling by US federal insurance program, Medicare…. July 28, 2022 - 4 minutesmins - By Liza Laws Share WhatsApp Twitter Linkedin Email
News and Trends 29 May 2020 Spanish Neurology Biotech Launches with €7.6M Series A …a large unmet demand in the sector, but neurological diseases have proved challenging for companies to target in the past. This is particularly true for diseases such as Alzheimer’s and… May 29, 2020 - 3 minutesmins - By Helen Albert Share WhatsApp Twitter Linkedin Email
News and Trends 8 Apr 2022 Epidarex Backs UK Startup Developing Emerging Anti-Inflammatory Drugs …from inflammatory diseases to neurodegenerative conditions including Huntington’s and Alzheimer’s disease. “KMO sits at a critical point in the kynurenine pathway, and the therapeutic blockade profoundly alters levels of several… April 8, 2022 - 3 minutesmins - By Jonathan Smith Share WhatsApp Twitter Linkedin Email
News and Trends 31 Jan 2017 New British Biotech-Academia Alliance takes on Cardiovascular Disease …key to treating many diseases, ranging from Alzheimer’s to cancer. However, their conformational flexibility in solution is a huge challenge that leads most candidates to fail. Heptares’ StaR technology addresses… January 31, 2017 - 2 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email
In Depth 14 May 2025 The stem cell race for Parkinson’s disease: Recent studies show significant promise …“big leap” in Parkinson’s treatment Parkinson’s is the second-most common neurodegenerative disorder after Alzheimer’s disease, with incidence rates increasing year on year. A study conducted in 2022 revealed that nearly… May 14, 2025 - 8 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
Best in Biotech 18 Apr 2024 5 RNA editing companies you should know about …innovators to design treatments across a wide range of diseases, including rare genetic disorders as well as debilitating conditions, such as Alzheimer’s, Parkinson’s, and many more. In August 2021, Shape… April 18, 2024 - 7 minutesmins - By Willow Shah-Neville Share WhatsApp Twitter Linkedin Email
News and Trends 11 Apr 2023 PsychoGenics launches eCube AI platform for drug discovery …research in areas such as Huntington’s disease, autism spectrum disorders, psychosis/schizophrenia, depression, PTSD, Alzheimer’s disease, Parkinson’s disease, muscular dystrophy, ALS and seizure disorders. PsychoGenics featured recently in Labiotech’s feature on… April 11, 2023 - 3 minutesmins - By Jim Cornall Share WhatsApp Twitter Linkedin Email
In Depth 25 Dec 2024 When biotech makes Christmas miracles a reality …biotech managed to make more manageable or to slow down yesterday could be cured tomorrow. For instance, we are discovering new approaches to Alzheimer’s disease giving us hope that one… December 25, 2024 - 8 minutesmins - By Jules Adam Share WhatsApp Twitter Linkedin Email
Opinion 17 Nov 2025 Precision psychiatry is the future of mental healthcare …underlying PTSD in a preclinical model. She completed her post-doctoral fellowship, which focused on models of aging and Alzheimer’s Disease, at Columbia University in the Departments of Psychiatry and Integrative… November 17, 2025 - 5 minutesmins - By External Contributor Share WhatsApp Twitter Linkedin Email
Best in Biotech 2 Sep 2021 The top 15 biotech companies to find in the Netherlands …intended target and the duration of its effects. In June 2021, the Netherlands headquartered biotech company raised $38 million to fund preclinical trials testing this approach in ALS and Alzheimer’s…. September 2, 2021 - 7 minutesmins - By Clara Rodríguez Fernández Share WhatsApp Twitter Linkedin Email